Early Treatment Diabetic Retinopathy Study
Early treatment diabetic retinopathy study etdrs the safety and scientific validity of this study is the responsibility of the study sponsor and investigators. The aim of the trials was to determine the impact of treatment with 32 mg of candesartan an angiotensin ii type 1 receptor blockade on the incidence and progression of diabetic retinopathy over a 4 year period. Visual Acuity Chart National Institutes Of Health Diabetic Listing a study does not mean it has been evaluated by the u s. Early treatment diabetic retinopathy study . The early treatment diabetic retinopathy study etdrs a multicenter collaborative clinical trial supported by the national eye institute was designed to assess whether argon laser photocoagulation or aspirin treatment can reduce the risk of visual loss or slow the progression of diabetic retinopathy in patients with mild to severe nonproliferative or early proliferative diabetic retinopathy. To provide an historical review of the early treatment diabetic...